Table 1.
Demographics and comorbidities in hospitalized Covid-19 patients.
Demographics | Total population–N(%)=522 (100) | Discharged–N(%)=430 (82.4%)a | Died–N(%)=92 (17.6%)b |
---|---|---|---|
Age (median, IQR) (yrs) | 63 (50−72) | 60 (50−70) | 70 (1−78) |
Femalec | 304 (58.2) | 262 (60.9) | 42 (45.7) |
African American | 454 (87) | 375 (87.2) | 79 (86) |
Caucasian | 59 (11.3) | 46 (10.7) | 13 (14.1) |
Commercial | 155 (29.7) | 143 (33.3) | 12 (13) |
Medicare | 283 (54.2) | 210 (48.8) | 73 (79.3) |
Medicaid | 25 (4.8) | 20 (4.7) | 5 (5.4) |
Uninsured | 58 (11.1) | 57 (13.3) | 1 (1.1) |
Other (Tricare) | 1 (0.2) | 0 (0) | 1 (1.1) |
Comorbidities/risk factors | |||
Hypertension | 416 (79.7) | 330 (76.7) | 86 (93.8) |
Diabetes mellitus | 221 (42.3) | 169 (39.3) | 52 (56.5) |
Coronary artery disease | 48 (9.2) | 35 (8.1) | 13 (14.1) |
Congestive heart failure | 70 (13.4) | 50 (11.6) | 20 (21.7) |
Chronic obstructive pulmonary disease | 47 (9) | 34 (7.9) | 13 (14.1) |
Asthma | 68 (13) | 57 (13.2) | 11 (12) |
Chronic kidney disease | 78 (14.9) | 58 (13.5) | 20 (21.7) |
End stage renal disease | 30 (5.8) | 23 (5.3) | 7 (7.6) |
Obesity (BMI ≥ 30) | 347 (66.5) | 290 (67.4) | 52 (62) |
Morbid obesity (BMI ≥ 40) | 134 (25.6) | 111 (25.8) | 23 (25) |
Cancer | 48 (9.2) | 39 (9.1) | 9 (9.8) |
Immunosuppression | 29 (5.6) | 17 (4) | 12 (13) |
Chronic liver disease | 6 (1.1) | 4 (0.9) | 2 (2.1) |
Former/current smoker | 89 (17) | 70 (16.3) | 18 (20.7) |
IQR: interquartile range; BMI: body mass index.
aPercentage based on denominator N = 522, remaining percentages in this column are based on denominator N = 430.
bPercentage based on denominator N = 522, remaining percentages in this column are based on denominator N = 92.
cOverall mortality in females was 13.8% and in males was 23%.